Markus Hansson
21 – 30 of 73
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Health-related quality of life in transplant ineligible newly diagnosed multiple myeloma patients treated with either thalidomide or lenalidomide-based regimen until progression : A prospective, open-label, multicenter, randomized, phase 3 study
- Contribution to journal › Article
- 2019
-
Mark
Transcriptome-wide association study of multiple myeloma identifies candidate susceptibility genes
- Contribution to journal › Article
-
Mark
Sequence variation at the MTHFD1L-AKAP12 and FOPNL loci does not influence multiple myeloma survival in Sweden
- Contribution to journal › Letter
-
Mark
Eosinophils in anti-neutrophil cytoplasmic antibody associated vasculitis
- Contribution to journal › Article
-
Mark
All-oral ixazomib, cyclophosphamide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma
- Contribution to journal › Article
-
Mark
Exposure levels from radiology procedures used in myeloma diagnostics
- Contribution to journal › Published meeting abstract
- 2018
-
Mark
A platform for phenotypic discovery of therapeutic antibodies and targets applied on Chronic Lymphocytic Leukemia
- Contribution to journal › Article
-
Mark
Bone marrow eosinophils in plasma cell disorders
- Contribution to journal › Article
-
Mark
Whole-exome sequencing exploration of acquired uniparental disomies in B-cell precursor acute lymphoblastic leukemia
- Contribution to journal › Article
-
Mark
Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma
- Contribution to journal › Article
